Indian pharmaceutical giants Sun Pharma and Glenmark are embracing Artificial Intelligence to speed up new drug creation. This technology promises to cut development times and costs. Global investment in AI for drug discovery is rapidly increasing. Companies are looking to AI for expertise and efficiency. This innovation is set to transform drug research and development cycles.
